My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Profound Medical Corp. - common stock
(NQ:
PROF
)
5.220
+0.100 (+1.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Profound Medical Corp. - common stock
< Previous
1
2
3
Next >
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
September 23, 2025
New program delivers TULSA Procedure’s precision treatment - minimal side effects, no overnight hospital stay – to Medicare patients across Texas
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
August 28, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Second Quarter 2025 Financial Results
August 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
July 24, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
June 10, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
June 04, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
May 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces First Quarter 2025 Financial Results
May 08, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
April 30, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
April 29, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
April 29, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
April 25, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
April 21, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
April 17, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
April 17, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical AUA 2025 Investor Event Agenda
April 15, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
April 12, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
April 07, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Profound Medical Corp. – PROF
April 03, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
March 30, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
March 26, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Save the Date: Profound Medical to Host Investor Event at AUA 2025
March 25, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
PROF Investors Have Opportunity to Join Profound Medical Corp. Fraud Investigation with the Schall Law Firm
March 21, 2025
From
The Schall Law Firm
Via
Business Wire
Securities Fraud Investigation Into Profound Medical Corp. (PROF) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
March 13, 2025
From
Glancy Prongay & Murray LLP
Via
Business Wire
Profound Medical Corp. (PROF) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
March 13, 2025
From
Law Offices of Howard G. Smith
Via
Business Wire
Securities Fraud Investigation Into Profound Medical Corp. (PROF) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
March 12, 2025
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results
March 06, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
February 13, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
January 13, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
January 08, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.